Biological function of Foot-and-mouth disease virus non-structural proteins and non-coding elements

Virology Journal

Volumn 13, Issue 1, 2016, Pages

  Gao, Yuan ^a   Sun, Shi Qi ^a   Guo, Hui Chen ^a  

^a INSTITUTE OF PLANT PROTECTION   (China)

Author keywords

[No Author keywords available]

Indexed keywords

4,4' DIISOTHIOCYANATOSTILBENE 2,2' DISULFONIC ACID; 5 (N,N HEXAMETHYLENE)AMILORIDE; AMANTADINE; FLUOROURACIL; N [5 (1 METHYL 1H PYRAZOL 4 YL) 2 NAPHTHOYL]GUANIDINE; NONSTRUCTURAL PROTEIN 2A; NONSTRUCTURAL PROTEIN 2B; NONSTRUCTURAL PROTEIN 2C; NONSTRUCTURAL PROTEIN 3A; NONSTRUCTURAL PROTEIN 3B; NONSTRUCTURAL PROTEIN 3C; NONSTRUCTURAL PROTEIN 3D; PROTEIN VP1; PROTEIN VP2; PROTEIN VP3; PROTEIN VP4; RIBAVIRIN; SINGLE STRANDED RNA; UNCLASSIFIED DRUG; VIRAL PROTEIN; VIRUS RNA; 3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION;

3' UNTRANSLATED REGION; 5' UNTRANSLATED REGION; ANTIVIRAL ACTIVITY; DRUG TARGETING; FOOT AND MOUTH DISEASE VIRUS; HUMAN; NONHUMAN; OPEN READING FRAME; PROTEIN FUNCTION; REVIEW; RNA TRANSLATION; VIRION; VIRUS CAPSID; VIRUS CELL INTERACTION; VIRUS GENOME; VIRUS INHIBITION; VIRUS REPLICATION; VIRUS VIRULENCE; ANIMAL; FOOT AND MOUTH DISEASE; GENE EXPRESSION REGULATION; GENETICS; METABOLISM; VIROLOGY;

3' UNTRANSLATED REGIONS; 5' UNTRANSLATED REGIONS; ANIMALS; FOOT-AND-MOUTH DISEASE; FOOT-AND-MOUTH DISEASE VIRUS; GENE EXPRESSION REGULATION, VIRAL; OPEN READING FRAMES; VIRAL NONSTRUCTURAL PROTEINS;

EID: 85007575243     PISSN: None     EISSN: 1743422X     Source Type: Journal    
DOI: 10.1186/s12985-016-0561-z     Document Type: Review

References (206)

1. Knowles NJ, Samuel AR. Molecular epidemiology of foot-and-mouth disease virus. Virus Res. 2003; 91: 65-80.
2. Haydon DT, Samuel AR, Knowles NJ. The generation and persistence of genetic variation in foot-and-mouth disease virus. Prev Vet Med. 2001; 51: 111-24.
3. Domingo E, Ruiz-Jarabo CM, Sierra S, Arias A, Pariente N, Baranowski E, Escarmis C. Emergence and selection of RNA virus variants: memory and extinction. Virus Res. 2002; 82: 39-44.
4. Domingo E, Pariente N, Airaksinen A, Gonzalez-Lopez C, Sierra S, Herrera M, Grande-Perez A, Lowenstein PR, Manrubia SC, Lazaro E, Escarmis C. Footand-mouth disease virus evolution: exploring pathways towards virus extinction. Curr Top Microbiol Immunol. 2005; 288: 149-73.
5. Klein J. Understanding the molecular epidemiology of foot-and-mouthdisease virus. Infect Genet Evol. 2009; 9: 153-61.
6. Grubman MJ. The 5' end of foot-and-mouth disease virion RNA contains a protein covalently linked to the nucleotide pUp. Arch Virol. 1980; 63: 311-5.
7. Lin JY, Chen TC, Weng KF, Chang SC, Chen LL, Shih SR. Viral and host proteins involved in picornavirus life cycle. J Biomed Sci. 2009; 16: 103.
8. Mason PW, Grubman MJ, Baxt B. Molecular basis of pathogenesis of FMDV. Virus Res. 2003; 91: 9-32.
9. Robertson BH, Grubman MJ, Weddell GN, Moore DM, Welsh JD, Fischer T, Dowbenko DJ, Yansura DG, Small B, Kleid DG. Nucleotide and amino acid sequence coding for polypeptides of foot-and-mouth disease virus type A12. J Virol. 1985; 54: 651-60.
10. Grubman MJ, Baxt B. Translation of foot-and-mouth disease virion RNA and processing of the primary cleavage products in a rabbit reticulocyte lysate. Virology. 1982; 116: 19-30.
11. Klump W, Marquardt O, Hofschneider PH. Biologically active protease of foot and mouth disease virus is expressed from cloned viral cDNA in Escherichia coli. Proc Natl Acad Sci U S A. 1984; 81: 3351-5.
12. Acharya R, Fry E, Stuart D, Fox G, Rowlands D, Brown F. The threedimensional structure of foot-and-mouth disease virus at 2. 9 A resolution. Nature. 1989; 337: 709-16.
13. Fry EE, Newman JW, Curry S, Najjam S, Jackson T, Blakemore W, Lea SM, Miller L, Burman A, King AM, Stuart DI. Structure of Foot-and-mouth disease virus serotype A10 61 alone and complexed with oligosaccharide receptor: receptor conservation in the face of antigenic variation. J Gen Virol. 2005; 86: 1909-20.
14. Fry EE, Stuart DI, Rowlands DJ. The structure of foot-and-mouth disease virus. Curr Top Microbiol Immunol. 2005; 288: 71-101.
15. Han SC, Guo HC, Sun SQ. Three-dimensional structure of foot-and-mouth disease virus and its biological functions. Arch Virol. 2015; 160: 1-16.
16. Belsham GJ. Translation and replication of FMDV RNA. Curr Top Microbiol Immunol. 2005; 288: 43-70.
17. Zibert A, Maass G, Strebel K, Falk MM, Beck E. Infectious foot-and-mouth disease virus derived from a cloned full-length cDNA. J Virol. 1990; 64: 2467-73.
18. Carrillo C, Tulman ER, Delhon G, Lu Z, Carreno A, Vagnozzi A, Kutish GF, Rock DL. High throughput sequencing and comparative genomics of foot-and-mouth disease virus. Dev Biol (Basel). 2006; 126: 23-30. discussion 323.
19. Carrillo C, Tulman ER, Delhon G, Lu Z, Carreno A, Vagnozzi A, Kutish GF, Rock DL. Comparative genomics of foot-and-mouth disease virus. J Virol. 2005; 79: 6487-504.
20. Mason PW, Bezborodova SV, Henry TM. Identification and characterization of a cis-acting replication element (cre) adjacent to the internal ribosome entry site of foot-and-mouth disease virus. J Virol. 2002; 76: 9686-94.
21. Gerber K, Wimmer E, Paul AV. Biochemical and genetic studies of the initiation of human rhinovirus 2 RNA replication: identification of a cisreplicating element in the coding sequence of 2A(pro). J Virol. 2001; 75: 10979-90.
22. Paul AV, Rieder E, Kim DW, van Boom JH, Wimmer E. Identification of an RNA hairpin in poliovirus RNA that serves as the primary template in the in vitro uridylylation of VPg. J Virol. 2000; 74: 10359-70.
23. Tiley L, King AM, Belsham GJ. The foot-and-mouth disease virus cis-acting replication element (cre) can be complemented in trans within infected cells. J Virol. 2003; 77: 2243-6.
24. Garcia-Nunez S, Gismondi MI, Konig G, Berinstein A, Taboga O, Rieder E, Martinez-Salas E, Carrillo E. Enhanced IRES activity by the 3'UTR element determines the virulence of FMDV isolates. Virology. 2014; 448: 303-13.
25. Kuhn R, Luz N, Beck E. Functional analysis of the internal translation initiation site of foot-and-mouth disease virus. J Virol. 1990; 64: 4625-31.
26. Fajardo Jr T, Rosas MF, Sobrino F, Martinez-Salas E. Exploring IRES region accessibility by interference of foot-and-mouth disease virus infectivity. PLoS One. 2012; 7: e41382.
27. Lopez de Quinto S, Saiz M, de la Morena D, Sobrino F, Martinez-Salas E. IRES-driven translation is stimulated separately by the FMDV 3'-NCR and poly(A) sequences. Nucleic Acids Res. 2002; 30: 4398-405.
28. Fernandez N, Fernandez-Miragall O, Ramajo J, Garcia-Sacristan A, Bellora N, Eyras E, Briones C, Martinez-Salas E. Structural basis for the biological relevance of the invariant apical stem in IRES-mediated translation. Nucleic Acids Res. 2011; 39: 8572-85.
29. Robertson ME, Seamons RA, Belsham GJ. A selection system for functional internal ribosome entry site (IRES) elements: Analysis of the requirement for a conserved GNRA tetraloop in the encephalomyocarditis virus IRES. RNA. 1999; 5: 1167-79.
30. Fernandez N, Buddrus L, Pineiro D, Martinez-Salas E. Evolutionary conserved motifs constrain the RNA structure organization of picornavirus IRES. FEBS Lett. 2013; 587: 1353-8.
31. Fernandez-Miragall O, Martinez-Salas E. Structural organization of a viral IRES depends on the integrity of the GNRA motif. RNA. 2003; 9: 1333-44.
32. Saleh L, Rust RC, Fullkrug R, Beck E, Bassili G, Ochs K, Niepmann M. Functional interaction of translation initiation factor eIF4G with the foot-and-mouth disease virus internal ribosome entry site. J Gen Virol. 2001; 82: 757-63.
33. de Breyne S, Yu Y, Unbehaun A, Pestova TV, Hellen CU. Direct functional interaction of initiation factor eIF4G with type 1 internal ribosomal entry sites. Proc Natl Acad Sci U S A. 2009; 106: 9197-202.
34. Pilipenko EV, Gmyl AP, Maslova SV, Svitkin YV, Sinyakov AN, Agol VI. Prokaryotic-like cis elements in the cap-independent internal initiation of translation on picornavirus RNA. Cell. 1992; 68: 119-31.
35. Martinez-Salas E. The impact of RNA structure on picornavirus IRES activity. Trends Microbiol. 2008; 16: 230-7.
36. Belsham GJ, Brangwyn JK. A region of the 5' noncoding region of foot-andmouth disease virus RNA directs efficient internal initiation of protein synthesis within cells: involvement with the role of L protease in translational control. J Virol. 1990; 64: 5389-95.
37. Lozano G, Fernandez N, Martinez-Salas E. Modeling Three-Dimensional Structural Motifs of Viral IRES. J Mol Biol. 2016; 428: 767-76.
38. Sonenberg N, Hinnebusch AG. Regulation of translation initiation in eukaryotes: mechanisms and biological targets. Cell. 2009; 136: 731-45.
39. Lopez-Lastra M, Ramdohr P, Letelier A, Vallejos M, Vera-Otarola J, Valiente-Echeverria F. Translation initiation of viral mRNAs. Rev Med Virol. 2010; 20: 177-95.
40. Plank TD, Kieft JS. The structures of nonprotein-coding RNAs that drive internal ribosome entry site function. Wiley Interdiscip Rev RNA. 2012; 3: 195-212.
41. Stassinopoulos IA, Belsham GJ. A novel protein-RNA binding assay: functional interactions of the foot-and-mouth disease virus internal ribosome entry site with cellular proteins. RNA. 2001; 7: 114-22.
42. Yu Y, Abaeva IS, Marintchev A, Pestova TV, Hellen CU. Common conformational changes induced in type 2 picornavirus IRESs by cognate trans-acting factors. Nucleic Acids Res. 2011; 39: 4851-65.
43. Martinez-Salas E, Francisco-Velilla R, Fernandez-Chamorro J, Lozano G, Diaz-Toledano R. Picornavirus IRES elements: RNA structure and host protein interactions. Virus Res. 2015; 206: 62-73.
44. Lopez de Quinto S, Martinez-Salas E. Interaction of the eIF4G initiation factor with the aphthovirus IRES is essential for internal translation initiation in vivo. RNA. 2000; 6: 1380-92.
45. Lopez de Quinto S, Lafuente E, Martinez-Salas E. IRES interaction with translation initiation factors: functional characterization of novel RNA contacts with eIF3, eIF4B, and eIF4GII. RNA. 2001; 7: 1213-26.
46. Lozano G, Martinez-Salas E. Structural insights into viral IRES-dependent translation mechanisms. Curr Opin Virol. 2015; 12: 113-20.
47. Luz N, Beck E. Interaction of a cellular 57-kilodalton protein with the internal translation initiation site of foot-and-mouth disease virus. J Virol. 1991; 65: 6486-94.
48. Luz N, Beck E. A cellular 57 kDa protein binds to two regions of the internal translation initiation site of foot-and-mouth disease virus. FEBS Lett. 1990; 269: 311-4.
49. Walter BL, Nguyen JH, Ehrenfeld E, Semler BL. Differential utilization of poly(rC) binding protein 2 in translation directed by picornavirus IRES elements. RNA. 1999; 5: 1570-85.
50. Bedard KM, Daijogo S, Semler BL. A nucleo-cytoplasmic SR protein functions in viral IRES-mediated translation initiation. EMBO J. 2007; 26: 459-67.
51. Pilipenko EV, Pestova TV, Kolupaeva VG, Khitrina EV, Poperechnaya AN, Agol VI, Hellen CU. A cell cycle-dependent protein serves as a template-specific translation initiation factor. Genes Dev. 2000; 14: 2028-45.
52. Pineiro D, Fernandez N, Ramajo J, Martinez-Salas E. Gemin5 promotes IRES interaction and translation control through its C-terminal region. Nucleic Acids Res. 2013; 41: 1017-28.
53. Lin JY, Li ML, Shih SR. Far upstream element binding protein 2 interacts with enterovirus 71 internal ribosomal entry site and negatively regulates viral translation. Nucleic Acids Res. 2009; 37: 47-59.
54. Merrill MK, Gromeier M. The double-stranded RNA binding protein 76: NF45 heterodimer inhibits translation initiation at the rhinovirus type 2 internal ribosome entry site. J Virol. 2006; 80: 6936-42.
55. Francisco-Velilla R, Fernandez-Chamorro J, Lozano G, Diaz-Toledano R, Martinez-Salas E. RNA-protein interaction methods to study viral IRES elements. Methods. 2015; 91: 3-12.
56. Andreev DE, Hirnet J, Terenin IM, Dmitriev SE, Niepmann M, Shatsky IN. Glycyl-tRNA synthetase specifically binds to the poliovirus IRES to activate translation initiation. Nucleic Acids Res. 2012; 40: 5602-14.
57. Serrano P, Pulido MR, Saiz M, Martinez-Salas E. The 3' end of the foot-andmouth disease virus genome establishes two distinct long-range RNA-RNA interactions with the 5' end region. J Gen Virol. 2006; 87: 3013-22.
58. Saiz M, Gomez S, Martinez-Salas E, Sobrino F. Deletion or substitution of the aphthovirus 3' NCR abrogates infectivity and virus replication. J Gen Virol. 2001; 82: 93-101.
59. Rueckert RR, Wimmer E. Systematic nomenclature of picornavirus proteins. J Virol. 1984; 50: 957-9.
60. Clarke BE, Sangar DV, Burroughs JN, Newton SE, Carroll AR, Rowlands DJ. Two initiation sites for foot-and-mouth disease virus polyprotein in vivo. J Gen Virol. 1985; 66(Pt 12): 2615-26.
61. Medina M, Domingo E, Brangwyn JK, Belsham GJ. The two species of the foot-and-mouth disease virus leader protein, expressed individually, exhibit the same activities. Virology. 1993; 194: 355-9.
62. Cao X, Bergmann IE, Fullkrug R, Beck E. Functional analysis of the two alternative translation initiation sites of foot-and-mouth disease virus. J Virol. 1995; 69: 560-3.
63. Piccone ME, Rieder E, Mason PW, Grubman MJ. The foot-and-mouth disease virus leader proteinase gene is not required for viral replication. J Virol. 1995; 69: 5376-82.
64. Lopez de Quinto S, Martinez-Salas E. Involvement of the aphthovirus RNA region located between the two functional AUGs in start codon selection. Virology. 1999; 255: 324-36.
65. Roberts PJ, Belsham GJ. Identification of critical amino acids within the footand-mouth disease virus leader protein, a cysteine protease. Virology. 1995; 213: 140-6.
66. Guarne A, Tormo J, Kirchweger R, Pfistermueller D, Fita I, Skern T. Structure of the foot-and-mouth disease virus leader protease: A papain-like fold adapted for self-processing and eIF4G recognition. EMBO J. 1998; 17: 7469-79.
67. Piccone ME, Zellner M, Kumosinski TF, Mason PW, Grubman MJ. Identification of the active-site residues of the L proteinase of foot-and-mouth disease virus. J Virol. 1995; 69: 4950-6.
68. Strebel K, Beck E. A second protease of foot-and-mouth disease virus. J Virol. 1986; 58: 893-9.
69. Mason PW, Piccone ME, McKenna TS, Chinsangaram J, Grubman MJ. Evaluation of a live-attenuated foot-and-mouth disease virus as a vaccine candidate. Virology. 1997; 227: 96-102.
70. Chinsangaram J, Mason PW, Grubman MJ. Protection of swine by live and inactivated vaccines prepared from a leader proteinase-deficient serotype A12 foot-and-mouth disease virus. Vaccine. 1998; 16: 1516-22.
71. Brown CC, Piccone ME, Mason PW, McKenna TS, Grubman MJ. Pathogenesis of wild-type and leaderless foot-and-mouth disease virus in cattle. J Virol. 1996; 70: 5638-41.
72. Kirchweger R, Ziegler E, Lamphear BJ, Waters D, Liebig HD, Sommergruber W, Sobrino F, Hohenadl C, Blaas D, Rhoads RE, et al. Foot-and-mouth disease virus leader proteinase: purification of the Lb form and determination of its cleavage site on eIF-4 gamma. J Virol. 1994; 68: 5677-84.
73. Devaney MA, Vakharia VN, Lloyd RE, Ehrenfeld E, Grubman MJ. Leader protein of foot-and-mouth disease virus is required for cleavage of the p220 component of the cap-binding protein complex. J Virol. 1988; 62: 4407-9.
74. Etchison D, Milburn SC, Edery I, Sonenberg N, Hershey JW. Inhibition of HeLa cell protein synthesis following poliovirus infection correlates with the proteolysis of a 220, 000-dalton polypeptide associated with eucaryotic initiation factor 3 and a cap binding protein complex. J Biol Chem. 1982; 257: 14806-10.
75. Chinsangaram J, Koster M, Grubman MJ. Inhibition of L-deleted foot-andmouth disease virus replication by alpha/beta interferon involves doublestranded RNA-dependent protein kinase. J Virol. 2001; 75: 5498-503.
76. Chinsangaram J, Piccone ME, Grubman MJ. Ability of foot-and-mouth disease virus to form plaques in cell culture is associated with suppression of alpha/beta interferon. J Virol. 1999; 73: 9891-8.
77. Wang D, Fang L, Liu L, Zhong H, Chen Q, Luo R, Liu X, Zhang Z, Chen H, Xiao S. Foot-and-mouth disease virus (FMDV) leader proteinase negatively regulates the porcine interferon-lambda1 pathway. Mol Immunol. 2011; 49: 407-12.
78. Friedman RM, Grimley P, Baron S. Biological effects of the interferons and other cytokines. Biotherapy. 1996; 8: 189-98.
79. Platanias LC. Mechanisms of type-I-and type-II-interferon-mediated signalling. Nat Rev Immunol. 2005; 5: 375-86.
80. de los Santos T, Segundo FD, Zhu J, Koster M, Dias CC, Grubman MJ. A conserved domain in the leader proteinase of foot-and-mouth disease virus is required for proper subcellular localization and function. J Virol. 2009; 83: 1800-10.
81. de Los Santos T, de Avila Botton S, Weiblen R, Grubman MJ. The leader proteinase of foot-and-mouth disease virus inhibits the induction of beta interferon mRNA and blocks the host innate immune response. J Virol. 2006; 80: 1906-14.
82. Wang D, Fang L, Luo R, Ye R, Fang Y, Xie L, Chen H, Xiao S. Foot-and-mouth disease virus leader proteinase inhibits dsRNA-induced type I interferon transcription by decreasing interferon regulatory factor 3/7 in protein levels. Biochem Biophys Res Commun. 2010; 399: 72-8.
83. Wang D, Fang L, Bi J, Chen Q, Cao L, Luo R, Chen H, Xiao S. Foot-andmouth disease virus leader proteinase inhibits dsRNA-induced RANTES transcription in PK-15 cells. Virus Genes. 2011; 42: 388-93.
84. Barral PM, Morrison JM, Drahos J, Gupta P, Sarkar D, Fisher PB, Racaniello VR. MDA-5 is cleaved in poliovirus-infected cells. J Virol. 2007; 81: 3677-84.
85. Wang D, Fang L, Li P, Sun L, Fan J, Zhang Q, Luo R, Liu X, Li K, Chen H, et al. The leader proteinase of foot-and-mouth disease virus negatively regulates the type I interferon pathway by acting as a viral deubiquitinase. J Virol. 2011; 85: 3758-66.
86. Bibeau-Poirier A, Servant MJ. Roles of ubiquitination in pattern-recognition receptors and type I interferon receptor signaling. Cytokine. 2008; 43: 359-67.
87. Isaacson MK, Ploegh HL. Ubiquitination, ubiquitin-like modifiers, and deubiquitination in viral infection. Cell Host Microbe. 2009; 5: 559-70.
88. Zhu Z, Yang F, Zhang K, Cao W, Jin Y, Wang G, Mao R, Li D, Guo J, Liu X, Zheng H. Comparative Proteomic Analysis of Wild-Type and SAP Domain Mutant Foot-and-Mouth Disease Virus-Infected Porcine Cells Identifies the Ubiquitin-Activating Enzyme UBE1 Required for Virus Replication. J Proteome Res. 2015; 14: 4194-206.
89. Hyrskyluoto A, Bruelle C, Lundh SH, Do HT, Kivinen J, Rappou E, Reijonen S, Waltimo T, Petersen A, Lindholm D, Korhonen L. Ubiquitin-specific protease-14 reduces cellular aggregates and protects against mutant huntingtininduced cell degeneration: involvement of the proteasome and ER stressactivated kinase IRE1alpha. Hum Mol Genet. 2014; 23: 5928-39.
90. Lindner HA, Fotouhi-Ardakani N, Lytvyn V, Lachance P, Sulea T, Menard R. The papain-like protease from the severe acute respiratory syndrome coronavirus is a deubiquitinating enzyme. J Virol. 2005; 79: 15199-208.
91. Kim ET, Oh SE, Lee YO, Gibson W, Ahn JH. Cleavage specificity of the UL48 deubiquitinating protease activity of human cytomegalovirus and the growth of an active-site mutant virus in cultured cells. J Virol. 2009; 83: 12046-56.
92. Lindner HA, Lytvyn V, Qi H, Lachance P, Ziomek E, Menard R. Selectivity in ISG15 and ubiquitin recognition by the SARS coronavirus papain-like protease. Arch Biochem Biophys. 2007; 466: 8-14.
93. Foeger N, Glaser W, Skern T. Recognition of eukaryotic initiation factor 4G isoforms by picornaviral proteinases. J Biol Chem. 2002; 277: 44300-9.
94. Donnelly ML, Gani D, Flint M, Monaghan S, Ryan MD. The cleavage activities of aphthovirus and cardiovirus 2A proteins. J Gen Virol. 1997; 78(Pt 1): 13-21.
95. Donnelly ML, Luke G, Mehrotra A, Li X, Hughes LE, Gani D, Ryan MD. Analysis of the aphthovirus 2A/2B polyprotein 'cleavage' mechanism indicates not a proteolytic reaction, but a novel translational effect: A putative ribosomal 'skip'. J Gen Virol. 2001; 82: 1013-25.
96. Donnelly ML, Hughes LE, Luke G, Mendoza H, ten Dam E, Gani D, Ryan MD. The 'cleavage' activities of foot-and-mouth disease virus 2A site-directed mutants and naturally occurring '2A-like' sequences. J Gen Virol. 2001; 82: 1027-41.
97. Sharma P, Yan F, Doronina VA, Escuin-Ordinas H, Ryan MD, Brown JD. 2A peptides provide distinct solutions to driving stop-carry on translational recoding. Nucleic Acids Res. 2012; 40: 3143-51.
98. Gao ZL, Zhou JH, Zhang J, Ding YZ, Liu YS. The silent point mutations at the cleavage site of 2A/2B have no effect on the self-cleavage activity of 2A of foot-and-mouth disease virus. Infect Genet Evol. 2014; 28: 101-6.
99. Ryan MD, Drew J. Foot-and-mouth disease virus 2A oligopeptide mediated cleavage of an artificial polyprotein. EMBO J. 1994; 13: 928-33.
100. Ryan MD, Belsham GJ, King AM. Specificity of enzyme-substrate interactions in foot-and-mouth disease virus polyprotein processing. Virology. 1989; 173: 35-45.
101. Ao D, Sun SQ, Guo HC. Topology and biological function of enterovirus non-structural protein 2B as a member of the viroporin family. Vet Res. 2014; 45: 87.
102. Nieva JL, Madan V, Carrasco L. Viroporins: structure and biological functions. Nat Rev Microbiol. 2012; 10: 563-74.
103. Ao D, Guo HC, Sun SQ, Sun DH, Fung TS, Wei YQ, Han SC, Yao XP, Cao SZ, Liu DX, Liu XT. Viroporin Activity of the Foot-and-Mouth Disease Virus Non-Structural 2B Protein. PLoS One. 2015; 10: e0125828.
104. Moffat K, Knox C, Howell G, Clark SJ, Yang H, Belsham GJ, Ryan M, Wileman T. Inhibition of the secretory pathway by foot-and-mouth disease virus 2BC protein is reproduced by coexpression of 2B with 2C, and the site of inhibition is determined by the subcellular location of 2C. J Virol. 2007; 81: 1129-39.
105. Moffat K, Howell G, Knox C, Belsham GJ, Monaghan P, Ryan MD, Wileman T. Effects of foot-and-mouth disease virus nonstructural proteins on the structure and function of the early secretory pathway: 2BC but not 3A blocks endoplasmic reticulum-to-Golgi transport. J Virol. 2005; 79: 4382-95.
106. Giorda KM, Hebert DN. Viroporins customize host cells for efficient viral propagation. DNA Cell Biol. 2013; 32: 557-64.
107. Sheppard HM, Verdon D, Brooks AE, Feisst V, Ho YY, Lorenz N, Fan V, Birch NP, Didsbury A, Dunbar PR. MicroRNA regulation in human CD8+ T cell subsets-cytokine exposure alone drives miR-146a expression. J Transl Med. 2014; 12: 292.
108. Scott C, Griffin S. Viroporins: structure, function and potential as antiviral targets. J Gen Virol. 2015; 96: 2000-27.
109. Gorbalenya AE, Koonin EV. Viral proteins containing the purine NTP-binding sequence pattern. Nucleic Acids Res. 1989; 17: 8413-40.
110. Teterina NL, Gorbalenya AE, Egger D, Bienz K, Rinaudo MS, Ehrenfeld E. Testing the modularity of the N-terminal amphipathic helix conserved in picornavirus 2C proteins and hepatitis C NS5A protein. Virology. 2006; 344: 453-67.
111. Klein M, Hadaschik D, Zimmermann H, Eggers HJ, Nelsen-Salz B. The picornavirus replication inhibitors HBB and guanidine in the echovirus-9 system: the significance of viral protein 2C. J Gen Virol. 2000; 81: 895-901.
112. Bienz K, Egger D, Troxler M, Pasamontes L. Structural organization of poliovirus RNA replication is mediated by viral proteins of the P2 genomic region. J Virol. 1990; 64: 1156-63.
113. Gosert R, Egger D, Bienz K. A cytopathic and a cell culture adapted hepatitis A virus strain differ in cell killing but not in intracellular membrane rearrangements. Virology. 2000; 266: 157-69.
114. Jecht M, Probst C, Gauss-Muller V. Membrane permeability induced by hepatitis A virus proteins 2B and 2BC and proteolytic processing of HAV 2BC. Virology. 1998; 252: 218-27.
115. Bolten R, Egger D, Gosert R, Schaub G, Landmann L, Bienz K. Intracellular localization of poliovirus plus-and minus-strand RNA visualized by strandspecific fluorescent In situ hybridization. J Virol. 1998; 72: 8578-85.
116. Troxler M, Egger D, Pfister T, Bienz K. Intracellular localization of poliovirus RNA by in situ hybridization at the ultrastructural level using single-stranded riboprobes. Virology. 1992; 191: 687-97.
117. Tesar M, Berger HG, Marquardt O. Serological probes for some foot-andmouth disease virus nonstructural proteins. Virus Genes. 1989; 3: 29-44.
118. Wang J, Wang Y, Liu J, Ding L, Zhang Q, Li X, Cao H, Tang J, Zheng SJ. A critical role of N-myc and STAT interactor (Nmi) in foot-and-mouth disease virus (FMDV) 2C-induced apoptosis. Virus Res. 2012; 170: 59-65.
119. Echeverri A, Banerjee R, Dasgupta A. Amino-terminal region of poliovirus 2C protein is sufficient for membrane binding. Virus Res. 1998; 54: 217-23.
120. Lippincott-Schwartz J. Bidirectional membrane traffic between the endoplasmic reticulum and Golgi apparatus. Trends Cell Biol. 1993; 3: 81-8.
121. Schlegel A, Giddings Jr TH, Ladinsky MS, Kirkegaard K. Cellular origin and ultrastructure of membranes induced during poliovirus infection. J Virol. 1996; 70: 6576-88.
122. Teterina NL, Gorbalenya AE, Egger D, Bienz K, Ehrenfeld E. Poliovirus 2C protein determinants of membrane binding and rearrangements in mammalian cells. J Virol. 1997; 71: 8962-72.
123. Saunders K, King AM. Guanidine-resistant mutants of aphthovirus induce the synthesis of an altered nonstructural polypeptide, P34. J Virol. 1982; 42: 389-94.
124. Saunders K, King AM, McCahon D, Newman JW, Slade WR, Forss S. Recombination and oligonucleotide analysis of guanidine-resistant footand-mouth disease virus mutants. J Virol. 1985; 56: 921-9.
125. Pfister T, Wimmer E. Characterization of the nucleoside triphosphatase activity of poliovirus protein 2C reveals a mechanism by which guanidine inhibits poliovirus replication. J Biol Chem. 1999; 274: 6992-7001.
126. Barton DJ, Flanegan JB. Synchronous replication of poliovirus RNA: initiation of negative-strand RNA synthesis requires the guanidine-inhibited activity of protein 2C. J Virol. 1997; 71: 8482-9.
127. Lubroth J, Brown F. Identification of native foot-and-mouth disease virus non-structural protein 2C as a serological indicator to differentiate infected from vaccinated livestock. Res Vet Sci. 1995; 59: 70-8.
128. Lubroth J, Grubman MJ, Burrage TG, Newman JF, Brown F. Absence of protein 2C from clarified foot-and-mouth disease virus vaccines provides the basis for distinguishing convalescent from vaccinated animals. Vaccine. 1996; 14: 419-27.
129. Lu Z, Zhang X, Fu Y, Cao Y, Tian M, Sun P, Li D, Liu Z, Xie Q. Expression of the major epitope regions of 2C integrated with the 3AB non-structural protein of foot-and-mouth disease virus and its potential for differentiating infected from vaccinated animals. J Virol Methods. 2010; 170: 128-33.
130. Meyer RF, Babcock GD, Newman JF, Burrage TG, Toohey K, Lubroth J, Brown F. Baculovirus expressed 2C of foot-and-mouth disease virus has the potential for differentiating convalescent from vaccinated animals. J Virol Methods. 1997; 65: 33-43.
131. Banerjee R, Dasgupta A. Interaction of picornavirus 2C polypeptide with the viral negative-strand RNA. J Gen Virol. 2001; 82: 2621-7.
132. Rodriguez PL, Carrasco L. Poliovirus protein 2C contains two regions involved in RNA binding activity. J Biol Chem. 1995; 270: 10105-12.
133. Adams P, Kandiah E, Effantin G, Steven AC, Ehrenfeld E. Poliovirus 2C protein forms homo-oligomeric structures required for ATPase activity. J Biol Chem. 2009; 284: 22012-21.
134. Rodriguez PL, Carrasco L. Poliovirus protein 2C has ATPase and GTPase activities. J Biol Chem. 1993; 268: 8105-10.
135. Tang WF, Yang SY, Wu BW, Jheng JR, Chen YL, Shih CH, Lin KH, Lai HC, Tang P, Horng JT. Reticulon 3 binds the 2C protein of enterovirus 71 and is required for viral replication. J Biol Chem. 2007; 282: 5888-98.
136. Sweeney TR, Cisnetto V, Bose D, Bailey M, Wilson JR, Zhang X, Belsham GJ, Curry S. Foot-and-mouth disease virus 2C is a hexameric AAA+ protein with a coordinated ATP hydrolysis mechanism. J Biol Chem. 2010; 285: 24347-59.
137. Zheng W, Li X, Wang J, Li X, Cao H, Wang Y, Zeng Q, Zheng SJ. A critical role of interferon-induced protein IFP35 in the type I interferon response in cells induced by foot-and-mouth disease virus (FMDV) protein 2C. Arch Virol. 2014; 159: 2925-35.
138. Fillmore RA, Mitra A, Xi Y, Ju J, Scammell J, Shevde LA, Samant RS. Nmi (NMyc interactor) inhibits Wnt/beta-catenin signaling and retards tumor growth. Int J Cancer. 2009; 125: 556-64.
139. Chen J, Naumovski L. Intracellular redistribution of interferon-inducible proteins Nmi and IFP 35 in apoptotic cells. J Interferon Cytokine Res. 2002; 22: 237-43.
140. Zhang L, Tang Y, Tie Y, Tian C, Wang J, Dong Y, Sun Z, He F. The PH domain containing protein CKIP-1 binds to IFP35 and Nmi and is involved in cytokine signaling. Cell Signal. 2007; 19: 932-44.
141. Chen J, Shpall RL, Meyerdierks A, Hagemeier M, Bottger EC, Naumovski L. Interferon-inducible Myc/STAT-interacting protein Nmi associates with IFP 35 into a high molecular mass complex and inhibits proteasome-mediated degradation of IFP 35. J Biol Chem. 2000; 275: 36278-84.
142. Lee ND, Chen J, Shpall RL, Naumovski L. Subcellular localization of interferoninducible Myc/stat-interacting protein Nmi is regulated by a novel IFP 35 homologous domain. J Interferon Cytokine Res. 1999; 19: 1245-52.
143. Zhou X, Liao J, Meyerdierks A, Feng L, Naumovski L, Bottger EC, Omary MB. Interferon-alpha induces nmi-IFP35 heterodimeric complex formation that is affected by the phosphorylation of IFP35. J Biol Chem. 2000; 275: 21364-71.
144. Ku BK, Kim SB, Moon OK, Lee SJ, Lee JH, Lyoo YS, Kim HJ, Sur JH. Role of apoptosis in the pathogenesis of Asian and South American foot-andmouth disease viruses in swine. J Vet Med Sci. 2005; 67: 1081-8.
145. de Los ST, Diaz-San Segundo F, Grubman MJ. Degradation of nuclear factor kappa B during foot-and-mouth disease virus infection. J Virol. 2007; 81: 12803-15.
146. Diaz-San Segundo F, Salguero FJ, de Avila A, de Marco MM, Sanchez-Martin MA, Sevilla N. Selective lymphocyte depletion during the early stage of the immune response to foot-and-mouth disease virus infection in swine. J Virol. 2006; 80: 2369-79.
147. O'Donnell V, Pacheco JM, LaRocco M, Burrage T, Jackson W, Rodriguez LL, Borca MV, Baxt B. Foot-and-mouth disease virus utilizes an autophagic pathway during viral replication. Virology. 2011; 410: 142-50.
148. Gannage M, Ramer PC, Munz C. Targeting Beclin 1 for viral subversion of macroautophagy. Autophagy. 2010; 6: 166-7.
149. Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death Differ. 2011; 18: 571-80.
150. Gladue DP, O'Donnell V, Baker-Branstetter R, Holinka LG, Pacheco JM, Fernandez-Sainz I, Lu Z, Brocchi E, Baxt B, Piccone ME, et al. Foot-andmouth disease virus nonstructural protein 2C interacts with Beclin1, modulating virus replication. J Virol. 2012; 86: 12080-90.
151. Knowles NJ, Davies PR, Henry T, O'Donnell V, Pacheco JM, Mason PW. Emergence in Asia of foot-and-mouth disease viruses with altered host range: characterization of alterations in the 3A protein. J Virol. 2001; 75: 1551-6.
152. Garcia-Briones M, Rosas MF, Gonzalez-Magaldi M, Martin-Acebes MA, Sobrino F, Armas-Portela R. Differential distribution of non-structural proteins of footand-mouth disease virus in BHK-21 cells. Virology. 2006; 349: 409-21.
153. Rosas MF, Vieira YA, Postigo R, Martin-Acebes MA, Armas-Portela R, Martinez-Salas E, Sobrino F. Susceptibility to viral infection is enhanced by stable expression of 3A or 3AB proteins from foot-and-mouth disease virus. Virology. 2008; 380: 34-45.
154. Beard CW, Mason PW. Genetic determinants of altered virulence of Taiwanese foot-and-mouth disease virus. J Virol. 2000; 74: 987-91.
155. Nunez JI, Baranowski E, Molina N, Ruiz-Jarabo CM, Sanchez C, Domingo E, Sobrino F. A single amino acid substitution in nonstructural protein 3A can mediate adaptation of foot-and-mouth disease virus to the guinea pig. J Virol. 2001; 75: 3977-83.
156. Harris JR, Racaniello VR. Amino acid changes in proteins 2B and 3A mediate rhinovirus type 39 growth in mouse cells. J Virol. 2005; 79: 5363-73.
157. Pacheco JM, Gladue DP, Holinka LG, Arzt J, Bishop E, Smoliga G, Pauszek SJ, Bracht AJ, O'Donnell V, Fernandez-Sainz I, et al. A partial deletion in nonstructural protein 3A can attenuate foot-and-mouth disease virus in cattle. Virology. 2013; 446: 260-7.
158. Giraudo AT, Beck E, Strebel K, de Mello PA, La Torre JL, Scodeller EA, Bergmann IE. Identification of a nucleotide deletion in parts of polypeptide 3A in two independent attenuated aphthovirus strains. Virology. 1990; 177: 780-3.
159. Ma X, Li P, Bai X, Sun P, Bao H, Lu Z, Cao Y, Li D, Chen Y, Qiao Z, Liu Z. Sequences outside that of residues 93-102 of 3A protein can contribute to the ability of foot-and-mouth disease virus (FMDV) to replicate in bovinederived cells. Virus Res. 2014; 191: 161-71.
160. De Diego M, Brocchi E, Mackay D, De Simone F. The non-structural polyprotein 3ABC of foot-and-mouth disease virus as a diagnostic antigen in ELISA to differentiate infected from vaccinated cattle. Arch Virol. 1997; 142: 2021-33.
161. Brocchi E, Bergmann IE, Dekker A, Paton DJ, Sammin DJ, Greiner M, Grazioli S, De Simone F, Yadin H, Haas B, et al. Comparative evaluation of six ELISAs for the detection of antibodies to the non-structural proteins of foot-andmouth disease virus. Vaccine. 2006; 24: 6966-79.
162. Clavijo A, Hole K, Li M, Collignon B. Simultaneous detection of antibodies to foot-and-mouth disease non-structural proteins 3ABC, 3D, 3A and 3B by a multiplexed Luminex assay to differentiate infected from vaccinated cattle. Vaccine. 2006; 24: 1693-704.
163. Sorensen KJ, de Stricker K, Dyrting KC, Grazioli S, Haas B. Differentiation of foot-and-mouth disease virus infected animals from vaccinated animals using a blocking ELISA based on baculovirus expressed FMDV 3ABC antigen and a 3ABC monoclonal antibody. Arch Virol. 2005; 150: 805-14.
164. Pacheco JM, Henry TM, O'Donnell VK, Gregory JB, Mason PW. Role of nonstructural proteins 3A and 3B in host range and pathogenicity of footand-mouth disease virus. J Virol. 2003; 77: 13017-27.
165. Carrillo C, Lu Z, Borca MV, Vagnozzi A, Kutish GF, Rock DL. Genetic and phenotypic variation of foot-and-mouth disease virus during serial passages in a natural host. J Virol. 2007; 81: 11341-51.
166. Paul AV, Wimmer E. Initiation of protein-primed picornavirus RNA synthesis. Virus Res. 2015; 206: 12-26.
167. Nayak A, Goodfellow IG, Belsham GJ. Factors required for the Uridylylation of the foot-and-mouth disease virus 3B1, 3B2, and 3B3 peptides by the RNA-dependent RNA polymerase (3Dpol) in vitro. J Virol. 2005; 79: 7698-706.
168. Nayak A, Goodfellow IG, Woolaway KE, Birtley J, Curry S, Belsham GJ. Role of RNA structure and RNA binding activity of foot-and-mouth disease virus 3C protein in VPg uridylylation and virus replication. J Virol. 2006; 80: 9865-75.
169. Falk MM, Sobrino F, Beck E. VPg gene amplification correlates with infective particle formation in foot-and-mouth disease virus. J Virol. 1992; 66: 2251-60.
170. Pacheco JM, Piccone ME, Rieder E, Pauszek SJ, Borca MV, Rodriguez LL. Domain disruptions of individual 3B proteins of foot-and-mouth disease virus do not alter growth in cell culture or virulence in cattle. Virology. 2010; 405: 149-56.
171. Birtley JR, Knox SR, Jaulent AM, Brick P, Leatherbarrow RJ, Curry S. Crystal structure of foot-and-mouth disease virus 3C protease. New insights into catalytic mechanism and cleavage specificity. J Biol Chem. 2005; 280: 11520-7.
172. Grubman MJ, Zellner M, Bablanian G, Mason PW, Piccone ME. Identification of the active-site residues of the 3C proteinase of foot-and-mouth disease virus. Virology. 1995; 213: 581-9.
173. Zunszain PA, Knox SR, Sweeney TR, Yang J, Roque-Rosell N, Belsham GJ, Leatherbarrow RJ, Curry S. Insights into cleavage specificity from the crystal structure of foot-and-mouth disease virus 3C protease complexed with a peptide substrate. J Mol Biol. 2010; 395: 375-89.
174. Sweeney TR, Roque-Rosell N, Birtley JR, Leatherbarrow RJ, Curry S. Structural and mutagenic analysis of foot-and-mouth disease virus 3C protease reveals the role of the beta-ribbon in proteolysis. J Virol. 2007; 81: 115-24.
175. Bablanian GM, Grubman MJ. Characterization of the foot-and-mouth disease virus 3C protease expressed in Escherichia coli. Virology. 1993; 197: 320-7.
176. Palmenberg AC. Proteolytic processing of picornaviral polyprotein. Annu Rev Microbiol. 1990; 44: 603-23.
177. Ypma-Wong MF, Dewalt PG, Johnson VH, Lamb JG, Semler BL. Protein 3CD is the major poliovirus proteinase responsible for cleavage of the P1 capsid precursor. Virology. 1988; 166: 265-70.
178. Belsham GJ, McInerney GM, Ross-Smith N. Foot-and-mouth disease virus 3C protease induces cleavage of translation initiation factors eIF4A and eIF4G within infected cells. J Virol. 2000; 74: 272-80.
179. Henikoff S. Nucleosome destabilization in the epigenetic regulation of gene expression. Nat Rev Genet. 2008; 9: 15-26.
180. Tesar M, Marquardt O. Foot-and-mouth disease virus protease 3C inhibits cellular transcription and mediates cleavage of histone H3. Virology. 1990; 174: 364-74.
181. Lawrence P, Schafer EA, Rieder E. The nuclear protein Sam68 is cleaved by the FMDV 3C protease redistributing Sam68 to the cytoplasm during FMDV infection of host cells. Virology. 2012; 425: 40-52.
182. Wang D, Fang L, Li K, Zhong H, Fan J, Ouyang C, Zhang H, Duan E, Luo R, Zhang Z, et al. Foot-and-mouth disease virus 3C protease cleaves NEMO to impair innate immune signaling. J Virol. 2012; 86: 9311-22.
183. Zhao T, Yang L, Sun Q, Arguello M, Ballard DW, Hiscott J, Lin R. The NEMO adaptor bridges the nuclear factor-kappaB and interferon regulatory factor signaling pathways. Nat Immunol. 2007; 8: 592-600.
184. Yang F, Yamashita J, Tang E, Wang HL, Guan K, Wang CY. The zinc finger mutation C417R of I-kappa B kinase gamma impairs lipopolysaccharideand TNF-mediated NF-kappa B activation through inhibiting phosphorylation of the I-kappa B kinase beta activation loop. J Immunol. 2004; 172: 2446-52.
185. Robertson BH, Morgan DO, Moore DM, Grubman MJ, Card J, Fischer T, Weddell G, Dowbenko D, Yansura D. Identification of amino acid and nucleotide sequence of the foot-and-mouth disease virus RNA polymerase. Virology. 1983; 126: 614-23.
186. George M, Venkataramanan R, Pattnaik B, Sanyal A, Gurumurthy CB, Hemadri D, Tosh C. Sequence analysis of the RNA polymerase gene of footand-mouth disease virus serotype Asia1. Virus Genes. 2001; 22: 21-6.
187. Ferrer-Orta C, Arias A, Escarmis C, Verdaguer N. A comparison of viral RNAdependent RNA polymerases. Curr Opin Struct Biol. 2006; 16: 27-34.
188. Ferrer-Orta C, Arias A, Perez-Luque R, Escarmis C, Domingo E, Verdaguer N. Structure of foot-and-mouth disease virus RNA-dependent RNA polymerase and its complex with a template-primer RNA. J Biol Chem. 2004; 279: 47212-21.
189. van Dijk AA, Makeyev EV, Bamford DH. Initiation of viral RNA-dependent RNA polymerization. J Gen Virol. 2004; 85: 1077-93.
190. Ferrer-Orta C, Arias A, Agudo R, Perez-Luque R, Escarmis C, Domingo E, Verdaguer N. The structure of a protein primer-polymerase complex in the initiation of genome replication. EMBO J. 2006; 25: 880-8.
191. Ferrer-Orta C, Ferrero D, Verdaguer N. RNA-Dependent RNA Polymerases of Picornaviruses: From the Structure to Regulatory Mechanisms. Viruses. 2015; 7: 4438-60.
192. Gruez A, Selisko B, Roberts M, Bricogne G, Bussetta C, Jabafi I, Coutard B, De Palma AM, Neyts J, Canard B. The crystal structure of coxsackievirus B3 RNAdependent RNA polymerase in complex with its protein primer VPg confirms the existence of a second VPg binding site on Picornaviridae polymerases. J Virol. 2008; 82: 9577-90.
193. Chen C, Wang Y, Shan C, Sun Y, Xu P, Zhou H, Yang C, Shi PY, Rao Z, Zhang B, Lou Z. Crystal structure of enterovirus 71 RNA-dependent RNA polymerase complexed with its protein primer VPg: implication for a trans mechanism of VPg uridylylation. J Virol. 2013; 87: 5755-68.
194. Sierra S, Davila M, Lowenstein PR, Domingo E. Response of foot-and-mouth disease virus to increased mutagenesis: influence of viral load and fitness in loss of infectivity. J Virol. 2000; 74: 8316-23.
195. Graci JD, Cameron CE. Quasispecies, error catastrophe, and the antiviral activity of ribavirin. Virology. 2002; 298: 175-80.
196. Airaksinen A, Pariente N, Menendez-Arias L, Domingo E. Curing of foot-andmouth disease virus from persistently infected cells by ribavirin involves enhanced mutagenesis. Virology. 2003; 311: 339-49.
197. Kumar R, Hosamani M, Sreenivasa BP, Kotyal A, Venkataramanan R. Expression of Foot-and-Mouth Disease Virus Non-Structural Protein, 3D in Insect Cells and its Application in Detection of Anti-FMDV Antibodies. Indian J Virol. 2012; 23: 326-32.
198. Almeida MR, Rieder E, Chinsangaram J, Ward G, Beard C, Grubman MJ, Mason PW. Construction and evaluation of an attenuated vaccine for footand-mouth disease: difficulty adapting the leader proteinase-deleted strategy to the serotype O1 virus. Virus Res. 1998; 55: 49-60.
199. Rodriguez-Calvo T, Diaz-San Segundo F, Sanz-Ramos M, Sevilla N. A replication analysis of foot-and-mouth disease virus in swine lymphoid tissue might indicate a putative carrier stage in pigs. Vet Res. 2011; 42: 22.
200. Horsington J, Zhang Z. Analysis of foot-and-mouth disease virus replication using strand-specific quantitative RT-PCR. J Virol Methods. 2007; 144: 149-55.
201. He C, Wang H, Wei H, Yan Y, Zhao T, Hu X, Luo P, Wang L, Yu Y. A recombinant truncated FMDV 3AB protein used to better distinguish between infected and vaccinated cattle. Vaccine. 2010; 28: 3435-9.
202. Nogueira Santos JA, Assis DM, Gouvea IE, Judice WA, Izidoro MA, Juliano MA, Skern T, Juliano L. Foot and mouth disease leader protease (Lbpro): Investigation of prime side specificity allows the synthesis of a potent inhibitor. Biochimie. 2012; 94: 711-8.
203. Guo C, Zhang C, Zheng H, Huang Y. Recombinant adenovirus expression of FMDV P1-2A and 3C protein and its immune response in mice. Res Vet Sci. 2013; 95: 736-41.
204. Dory D, Remond M, Beven V, Cariolet R, Zientara S, Jestin A. Foot-and-Mouth Disease Virus neutralizing antibodies production induced by pcDNA3 and Sindbis virus based plasmid encoding FMDV P1-2A3C3D in swine. Antiviral Res. 2009; 83: 45-52.
205. Chang Y, Dou Y, Bao H, Luo X, Liu X, Mu K, Liu Z, Liu X, Cai X. Multiple microRNAs targeted to internal ribosome entry site against foot-and-mouth disease virus infection in vitro and in vivo. Virol J. 2014; 11: 1.
206. Han SC, Guo HC, Sun SQ, Jin Y, Wei YQ, Feng X, Yao XP, Cao SZ, Xiang Liu D, Liu XT. Productive Entry of Foot-and-Mouth Disease Virus via Macropinocytosis Independent of Phosphatidylinositol 3-Kinase. Sci Rep. 2016; 6: 19294.